Add listing
    0
    Add listing
    Listing cover image

    EvlaBio AG Verified listing

    • Swiss Biotech Association
      Member

    EvlaBio is a life science startup dedicated to the development of first-in-class therapeutics in the cardiovascular and cardiorenal space. The lead asset is a Therapeutic Monoclonal Antibody (mAb) targeting unphysiological FGFR4/FGF23 cardiac overdrive in the setting of chronic kidney disease (CKD).

    Location
    Additional address info
    • c/o ABT Treuhandgesellschaft AG
    Canton
    Facts & figures
    • Type of organization
      Private company
    • Year of foundation
      2022
    • Number of employees in Switzerland
      1-9
    Key business

    You may also be interested in